Gofore Oyj
GOFORE PLC MANAGERS’ TRANSACTIONS 18 MARCH 2021 AT 16.02 EET
Gofore Plc: Managers' transactions - Talvinko
Person subject to the notification requirement
Name: Talvinko, Teppo
Position: Chief Financial Officer
Issuer: Gofore Plc
LEI: 743700JIW1LAUZDH9012
Notification type: INITIAL NOTIFICATION
Reference number: 743700JIW1LAUZDH9012_20210318122334_9
____________________________________________
Transaction date: 2021-03-17
Venue not applicable
Instrument type: SHARE
ISIN: FI4000283130
Nature of the transaction: SUBSCRIPTION
Transaction details
(1): Volume: 109 Unit price: 16.4523 EUR
Aggregated transactions
(1): Volume: 109 Volume weighted average price: 16.4523 EUR
Further enquiries:
Teppo Talvinko, CFO, Gofore Plc
Tel. +358 40 715 3660
teppo.talvinko@gofore.com
Certified Adviser: Evli Bank Plc, tel. +358 40 579 6210
Gofore Plc is a Finland-based digitalisation specialist with international growth plans. Together with our customers, we are pioneering an ethical digital world. We're made up of over 700 impact-driven people across Finland, Germany, Spain and Estonia – top experts in our industry who are our company's heart, brain, and hands. We use consulting, coding and design as tools to incite positive change. We care for our people, our customers, and the surrounding world. Our values guide our business: Gofore is a great workplace that thrives on customer success. In 2020, our net sales amounted to EUR 78 million. Gofore Plc's shares are quoted in the Nasdaq First North Growth Market Finland. Learn more: www.gofore.com.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biogen Inc.14.10.2025 01:30:00 CEST | Press release
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”
Bombardier Inc.13.10.2025 22:02:56 CEST | Press release
Bombardier Global 8000, The World’s Fastest Business Jet, Gets Even Faster with a New Top Speed of Mach 0.95
Zymeworks Inc.13.10.2025 22:00:00 CEST | Press release
Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference
Bombardier Inc.13.10.2025 21:00:00 CEST | Press release
Bombardier Unveils Comlux as Global 8000 Aircraft Customer, Delivery Confirmed for 2026
Cosmos Health Inc.13.10.2025 20:05:46 CEST | Press release
Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom